AstraZeneca India gets dual CDSCO approval for Trastuzumab deruxtecan
Additional indications for treatment of HER2 low breast cancer and HER2 positive gastric / gastro-oesophageal cancer
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.